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ABSTRACT 
Background and Purpose: The purpose of this study was to evaluate gait 
kinematics of individuals without pathological impairments. Through the use of 
electromyography (EMG), the firing of muscles was analyzed during ambulation using 
the partial body weight support treadmill training (PBWSTT). Video motion analysis 
(VMA) was also used to look at the movements of the lower extremities and the pelvis. 
Using both of these tools, it was determined ifthere was a significant change in muscle 
firing and movements in normal individuals during ambulation with weight support 
compared to normal weight-bearing. Methods: Four subjects (3 female, 1 male) were 
recruited for this study. EMG and VMA data was collected for lower extremity musCle 
activity and gait kinematics during the gait cycle at 0%, slack removed (3%-6%), 15%, 
and 30% body weight support. Results: The gluteus medius muscle activation was found 
to be significantly different between conditions (F(3,8) = 11.446; P = 0.003). A post-hoc 
analysis was found to show significant differences in gluteus medius activation between 
0% vs 3-6% (p = 0.017),0% vs 15% (p = 0.016),3-6% vs 30% (p = 0.015), 15% vs 30% 
(p = 0.015). The gluteus medius was most active at 15% (132.2%) followed by 3-6% 
(129.65%) The remaining muscles did not show significant difference in muscle 
activation and weight-bearing percentages. It is also noted that the power for these 
muscles were quite low. Step length was found to be significantly different between 
weight bearing conditions (p = 0.005). A post hoc analysis was performed, and Scheffe 
Vlll 
results showed significant differences in step length between 0% vs 3-6% (p = 0.016) and 
0% vs 30% (p = 0.009). Step length was greatest at 0% BWS for all SUbjects. Ankle 
dorsiflexion was not found to be significant (p = 2.176, power = 0.383). Conclusion: It 
was found that PBWSTT did not significantly alter the EMG data ofnonnal individuals. 
This, in tum, will allow future studies to be perfonned on individuals who have 
impainnents and limitations knowing that further compensation patterns will not be 
elicited from the use ofPBWSTT. 
IX 
CHAPTER I 
INTRODUCTION 
Gait dysfunction is a common result of stroke, traumatic brain injury, spinal cord 
injury and other neurological insults. l -4 Many individuals who have suffered from these 
insults are non-ambulatory for some length of time; therefore, gait training is one of the 
components of the rehabilitation process. Traditionally, physical therapists have focused 
on strengthening and single-movement practices.5 However, current approaches 
concentrate on task-specific therapies that are a normal part of an individual's activities 
of daily living (ADLs). These task-specific therapies may include transfer training which 
allows individuals to safely sit down and rise from chairs as they would in their home and 
community and gait training which allows for mobility and independence. The use of 
partial body weight support treadmill training (PBWSTT) can be included in these task-
specific therapies. 
PBWSTT allows a patient to perform multiple, complex ambulatory movements 
which has shown to be more effective than single-movement therapy approaches for gait 
training.2,4,6,7 This is done by decreasing the patient's body weight by a given percentage 
through the use of a supportive hamess.8-10 Utilization of the PBWSTT allows a patient 
to ambulate correctly early on in the rehabilitation process. This is accomplished by 
providing trunk stabilization, which allows for weight transfer and loading of the lower 
extremities under supervision and facilitation provided by a physical therapist.8,9,11,12 
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Current literature has shown the use of 30% body weight support (BWS) for 
rehabilitation provides appropriate support without altering normal gait patterns when 
compared to full weight bearing. 13 Through the use of electromyography (EMG) and 
video motion analysis (VMA), this study hopes to prove that PBWSTT at 30% BWS and 
less will produce gait parameters most resembling the parameters at full weight bearing. 
Problem statement 
PBWSTT has been used during the rehabilitation process for many neurological 
disorders. Due to the fact body weight is reduced, there is a possibility that patients may 
compensate and develop poor habits while ambulating on the treadmill that may persist. 
Motor re-learning could be affected due to the activation of muscles at inappropriate 
times during the gait cycle. This could inevitably affect over-ground ambulation after the 
rehabilitation process is complete. 
Purpose of the study 
The purpose of this study was to evaluate gait kinematics of individuals without 
pathological impairments. Through the use ofEMG, the firing of muscles was analyzed 
during ambulation using the PBWSTT. VMA was also used to look at the movements of 
the lower extremities and the pelvis. Using both of these tools, it was determined ifthere 
was a significant change in muscle firing and movements in normal individuals during 
ambulation with weight support compared to normal weight-bearing. 
Significance of the study 
This study looked at muscle activation and gait kinematics using EMG and VMA, 
respectively. Using the information gathered, it was determined ifPBWSTT 
significantly alters normal individuals' gait patterns at various body weight support 
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percentages when compared to full weight-bearing. If there were no significant 
alterations of gait using PBWSTT on normal subjects, this would indicate that current use 
ofPBWSTT on patients with neurological conditions is beneficial. With these results, 
future studies can be conducted to apply the specific findings from this study to 
populations who may benefit from such task-specific gait training. 
Research questions 
1. Is there a difference in muscle activation between full weight-bearing ambulation 
and body-weight supported ambulation? 
2. Is there a difference in gait kinematics between full weight-bearing ambulation 
and body-weight supported ambulation? 
Hypotheses - Null (HO) and Alternate (HA) 
Ia. HO = There will be no significant difference in muscle activation between full 
weight-bearing ambulation (0% body weight support (BWS)) and slack removed 
supported ambulation (3-6% BWS). 
HA = There will be a significant difference in muscle activation between full 
weight-bearing ambulation (0% BWS) and slack removed supported ambulation 
(3-6% BWS). 
1 b. HO = There will be no significant difference in muscle activation between full 
weight-bearing ambulation (0% BWS) and 15% BWS. 
HA = There will be a significant difference in muscle activation between full 
weight-bearing ambulation (0% BWS) and 15% BWS. 
Ic. HO = There will be no significant difference in muscle activation between full 
weight-bearing ambulation (0% BWS) and 30% BWS. 
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HA = There will be a significant difference in muscle activation between full 
weight-bearing ambulation (0% BWS) and 30% BWS. 
2a. HO = There will be no significant difference in gait kinematics between full 
weight-bearing ambulation (0% BWS) and slack removed supported ambulation 
(3-6% BWS), 
HA = There will be a significant difference in gait kinematics between full 
weight-bearing ambulation (0% BWS) and slack removed supported ambulation 
(3-6% BWS). 
2b. HO = There will be no significant difference in gait kinematics between full 
weight-bearing ambulation (0% BWS) and 15% BWS. 
HA = There wiiI be a significant difference in gait kinematics between full 
weight-bearing ambulation (0% BWS) and 15% BWS. 
2c. HO = There will be no significant difference in gait kinematics between full 
weight-bearing ambulation (0% BWS) and 30% BWS. 
HA = There will be a significant difference in gait kinematics between full 
weight-bearing ambulation (0% BWS) and 30% BWS. 
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Biomechanics of Gait 
CHAPTERll 
LITERATURE REVIEW 
Gait is defined as an alternating, rhythmic movement of the limbs of the body 
along with the trunk which results in forward movement of the center of gravity. 14 The 
goal of normal gait is to move forward while conserving energy and absorbing the impact 
ofthe resultant forces from the floor. There are five determinants of gait which help to 
decrease energy expenditure while ambulating. 14 The first determinant is pelvic tilt. As a 
person walks, the pelvis will tilt downward on the stance leg in order to lower the center 
of mass. The second determinant is knee flexion at mid stance, which also helps to lower 
the center of mass. The third determinant of gait is knee, ankle and foot interaction 
which takes place twice during the gait cycle. The first time is during initial contact 
when the knee flexes, the ankle plantarflexes and the foot pronates for shock absorption. 
The second time is during mid stance; the interaction helps to slow the descent of the 
center of mass by extending the knee, plantarflexing the ankle and supinating the foot. 
The fourth determinant is pelvic rotation. During this action, the pelvis will rotate four 
degrees forward and backward to prevent the center of mass from dropping significantly. 
Lastly, the fifth determinant of gait is physiological valgus of the knee which helps to 
reduce the lateral displacement of the center of mass during gait. 
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The Gait Cycle 
Each gait cycle, defined as the time between initial contact and the following 
ipsilateral initial contact, consists of eight defined phases. IS The phases listed below are 
defined in relation to the right foot and can be identified in Figure One. 
1. Initial Contact (lC) - point at which the right heel strikes the ground. 
2. Loading Response (LR) - the weight of the person is transferred onto the 
right limb. 
3. Mid Stance (MSt) - body is centered over the right limb. 
4. Terminal Stance (TSt) - trunk moves over the right limb and weight is transferred 
onto the forefoot. 
5. Pre-Swing (PSw) - weight is taken off of the right limb and transferred onto the 
left. 
6. Initial Swing (lsw) - as the right foot comes off the floor, the thigh advances 
forward. 
7. Mid Swing (MSw) - right thigh advances as the foot clears the floor. 
8. Terminal Swing (TSw) - right knee extends to enable the limb to prepare for 
initial contact. 
~ C C> 0 b ! l I ~ ! l I 0 () 0 D 
/\ \\ f\ /\ 1\ T\ tl 1\ / \. (\. L L I .~ /L <L L \y 
.... 
IC LR MSt TSt PSw ISw MSw TSw 
Figure 1: Phases of gait cycle (Figure adapted from Ranchos Los AmigoslS) 
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Each of these phases of the gait cycle has identifiable components which include specific 
pelvic and lower extremity muscular activity and joint range of motion (ROM). 
Initial contact is considered to take place at 0% ofthe gait cycle. 15 At this 
moment, the primary muscles activated are the hip extensors, knee flexors, knee 
extensors, and ankle dorsiflexors. Expected joint ROM includes: 200 of hip flexion, 50 of 
knee flexion, and 00 ankle of plantarflexion. 
Loading response takes place from 0-12% of the gait cycle. 15 The primary 
muscles activated include hip extensors, knee flexors and extensors, and ankle 
dorsiflexors. During this phase, the gluteus maximus, gluteus medius, tensor fascia latae, 
and adductor magnus have their peak muscle activation. Expected joint ROM includes: 
20° of hip flexion, 15° of knee flexion, and 5° of ankle plantarflexion. 
Mid stance occurs from 12-31 % of the gait cycle. 15 Muscle activation during this 
phase includes the hip extensors and abductors, knee flexors, and ankle plantarflexors. 
The expected joint ROM includes: 00 of hip flexion, 50 of knee flexion, and 50 of ankle 
dorsiflexion. 
Terminal stance takes place between 31-50% of the gait cycle. 15 The primary 
muscles activated are the hip abductors and ankle plantarflexors. Expected joint ROM is 
as follows: 200 of hip extension, 50 of knee flexion, and 100 of ankle dorsiflexion. 
Pre-swing occurs between 50-62% of the gait cycle. 15 Muscles activated at this 
time include the hip adductors, knee extensors, and ankle plantarflexors. The rectus 
femoris is at its peak contraction during this phase. Expected joint ROM is 10° of hip 
extension, 400 of knee flexion, and 150 of ankle plantarflexion. 
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Initial swing occurs from 62-75% of the gait cycle. 15 Muscles active at this time 
include the hip flexors, hip adductors, knee flexors, knee extensors, and ankle 
dorsiflexors. The iliacus, gracilis, and sartorius are at their peak activation during this 
phase. Expected joint ROM is 15° of hip flexion, 60° of knee flexion, and 5° of ankle 
plantarflexion. 
Mid swing occurs from 75-87% ofthe gait cycle. 15 Active muscles are the hip 
extensors, hip flexors, knee flexors, and ankle dorsi flexors. Expected joint ROM is 25° 
of hip flexion, 25° of knee flexion, and 0° of ankle dorsiflexion. 
Terminal swing is the final phase ofthe gait cycle, and it occurs from 87-100% of 
the gait cycle. 15 Active muscles include the hip extensors, hip adductors, knee flexors, 
knee extensors, and ankle dorsiflexors. The long head of the biceps femoris, 
semitendinosis and semimembranosis are most active during this phase. The expected 
ROM includes: 20° of hip flexion, 5° of knee flexion, and 0° of ankle dorsiflexion. 
Partial Body Weight Support Treadmill Training (PBWSTT) 
The gait cycle consists of complex movements that require the ability of an 
individual to go through these movements in a coordinated fashion. Utilization of 
PBWSTT allows people with impairments and functional limitations resulting from 
neurological and musculoskeletal insults to perform this complex cycle more easily as 
they recover. 
Multiple studies have shown gait training using PBWSTT leads to improved 
recovery when compared to gait training by focusing on one part of the gait cycle at a 
time. 1,16 There are three main elements of ambulation that are addressed specifically by 
PBWSTT: 1) locomotion is achieved with the treadmill belt, 2) equilibrium reflexes are 
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compensated for through the use ofthe harness, and 3) the amount of weight-bearing is 
dependent on the level of assistance needed by the individual. 8 All of these elements lead 
to a safe walking environment which allows individuals to focus on the aspects of their 
gait cycle and not on balance. 1,4 PBWSTT makes it easier for people to begin working 
on task-specific gait training in high volume without requiring time early on after the 
insult to work on single elements of the gait cycle. 12,16,17 PBWSTT allows individuals 
with neurological insults to complete up to 1000 gait cycles during a single, 3D-minute 
therapy session.5,8,18 Using traditional, over-ground gait-training therapy, the individual 
may only complete 50 or less gait cycles during one session.5 Individuals with more 
acute injuries and insults have been shown to have greater benefits from PBWSTT then 
people with more chronic injuries. 19 
Cerebrovascular Accident 
Up to 80% of patients post-cerebrovascular accident (CVA) suffer from gait 
deficiencies that may lead to wheelchair dependency or severe gait abnormalities.5 Gait 
velocity may be reduced up to 50% in these individuals when compared to a healthy 
adult. This is due to the fact that the phases of their gait cycle are altered. I Often times, 
the individuals are unable to control the muscles of the pelvis and lower extremities due 
to their neurological impairments. This ultimately affects the individual's ability to 
perform the gait cycle appropriately. PBWSTT has been shown to eliminate equilibrium 
reflexes and forces the patient to go through the complex gait pattern. 12 Early 
implementation ofPBWSTT improves individuals' function by reducing the tendency to 
develop substitution patterns in their gait by "utilizing residual pathways and potentially 
increasing the amount of neurological recovery". 20 (p 120) 
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Visintin et al 16 reported that six weeks ofPBWSTT caused significant 
improvement in balance, over-ground walking speed, endurance, and motor recovery 
when compared to subjects that simply walked on treadmill without body weight support 
(BWS). The scores for motor recovery and walking speed were still significantly better 
than the control group after three months. Trueblood l recruited 13 people post-CVA; 
eight to perform PBWSTT for six weeks (three times per week for 75 minutes per session 
of individualized PBWSTT) and five for a control group. Each individual was tested 
before and after the interventions using the Tinetti Gait and Balance and Six Minute 
Walk test. It was found that there were significant differences between the experimental 
and control groups in the Tinetti Balance (p=0.031) and total Tinetti score (p=0.011). 
There was no significant difference between groups in the Six Minute Walk Test. 
Hesse et al21 compared seven non-ambulatory patients with hemiparesis in an 
ABA single case-study design comparing PBWSTT (part A) with Bobath-theory 
physiotherapy (part B). Each phase ofthe design lasted for three weeks, and the subjects 
were assessed using the Function Ambulation Category (F AC), Rivermead Motor 
Assessment, and gait cycle parameters. These assessments were performed prior to the 
study and after the completion of each phase of the ABA cycle. Results showed that 
treadmill training was more effective in restoring gait ability and walking velocity when 
compared to the Bobath physiotherapy approaches. The F AC levels improved only 
during the PBWSTT stage of the ABA design. 
Spinal Cord Injury 
In a study by Field-Fote and Tepavac22, patients with incomplete spinal cord 
injury (SCI) above the level ofTlO (American Spinal Injury Association (ASIA) Level 
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C) (Appendix A) completed a 12-week walking program that consisted ofPBWSTT and 
electrical stimulation. The speed of the treadmill was increased gradually by 0.1 mls 
until the patients reached a speed at which they felt comfortable walking. During the 
walking program, the BWS and speed were adjusted to allow the subjects to walk without 
gait abnormalities. Each subject participated in 36 treatment sessions lasting 
approximately 90 minutes. At the conclusion ofthe study, it was found that this 
combination provided the best sensory environment to help individuals with SCIs 
improve upon their walking ability.22 On average, over ground walking speed was 84% 
greater and treadmill walking speed was 158% faster when compared to pre-training 
levels. 
Field-Fotel3 recruited subjects with SCI (ASIA C) who were at least one-year 
post-injury for a study. In this study, subjects performed PBWSTT 1.5 hours per day, 3 
days per week for 3 months along with electrical stimulation of the common peroneal 
nerve of the weaker lower extremity. The speed of the treadmill and BWS were self-
determined by the patient in order to allow for optimal walking kinematics. BWS was 
never greater than 30%, and the subjects were encouraged to walk as fast as they could 
while maintaining appropriate gait kinematics. Significant increases were found for each 
individual in over-ground walking speed (improved from 0.12 +/- 0.8 mls to 0.21 +/- 0.15 
mls) and treadmill speed (improved from 0.23 +/- 0.12 mls to 0.49 +/- 0.2 mls) and 
treadinill distance (improved from 93 +/- 84 meters to 243 +/- 139 meters). \3 
A study by Nymark et at2° was conducted with subjects who had variable SCI that 
ranged from C2-T10. In addition to PBWSTT, these subjects performed traditional 
therapies such as weight-shifting, balance, endurance, stretching, and strengthening. 
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PBWSTT was primarily utilized during spontaneous neurological recovery to regain a 
more appropriate gait cycle. Four of the five subjects demonstrated improvements in 
strength, endurance, and ability to ambulate without body-weight support. The four 
subjects also had improvements in joint motion and EMG results that correlated with 
improved gait function. 2o Visintin and Barbeau stated that: 
BWS has been shown to facilitate gait and elicit a more 
normal gait pattern with respect to sagittal angular 
displacement patterns, temporal distance parameters, and 
EMG activity of lower limb muscles in a group of spastic 
paretic subjects during PBWSTT.24 (p 541) 
Orthopedic and other diagnoses: 
Threlkeld et allo also support the use ofPBWSTT to facilitate functional 
ambulation after neurologic pathologies as well as assist in recovery following 
musculoskeletal injuries. Hesse et alii studied the effects of PBWSTT versus traditional 
physical therapy in patients post-total hip arthroplasty. Eighty subjects who could walk 
independently with crutches were recruited for this study. The control group received 45 
minutes of physical therapy days one through ten. Their traditional physical therapy 
consisted of passive knee and hip joint range of motion, strengthening of hip adductors 
and extensors according to the proprioceptive neuromuscular facilitation (PNF) concepts, 
and gait retraining on level ground and stairs at each session. The treatment group 
received PBWSTT for 25 minutes followed by 20 minutes of physical therapy on days 1-
5 and 35 minutes ofPBWSTT followed by 10 minutes of physical therapy on days 6-10. 
These individuals received passive knee and hip joint mobilization at each session. The 
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Harris score was utilized for assessing these subjects both pre and post-training, and it 
was found that the PBWSTT group scored 13.6 points higher than the traditional physical 
therapy group after training was completed. Subjects in the PBWSTT also ceased using 
crutches five weeks earlier (three weeks versus eight weeks) than the physical therapy 
group. 11 
People with a diagnosis with Parkinson's disease may also benefit from the use of 
PBWSTT. Miyai et af5 worked with 10 patients with Parkinson's disease; the subjects 
performed either PBWSTT or physical therapy for four weeks. Physical therapy 
consisted of general conditioning, range of motion, ADL training, and gait training. The 
PBWSTT consisted of walking with 20% BWS for 12 minutes, 4.5 minutes rest, walking 
with 10% BWS for 12 minutes, 4.5 minutes rest, and then walking with 0% BWS for 12 
minutes. Results using the Unified Parkinson's Disease Rating Scale (UPDRS) were 
determined before and after treatment; the PBWSTT group had a significant decrease in 
their UPDRS scores when compared to the physical therapy group. 
Schindl et a17 took baseline measurements at six weeks and three weeks pre-study, 
beginning of the study, and following the study of the functional ambulation category 
(F AC) and the standing and walking sections of the gross motor function measure 
(GMFM). The study looked at 10 children with cerebral palsy over a span of three 
months over which PBWSTT was performed three times a week, 30 minutes per 
treatment session. The BWS ranged from 0% to 40%. At the conclusion of the study, 
results showed both the FAC and GMFM scores improved significantly after PBWSTT. 
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General Parameters: 
There are multitudes of body-weight percentages and treadmill speed 
combinations that may be used with PBWSTT. Body-weight support can range from 
10% to 70%, but many of these amounts may not be practical for therapeutic uses. 10 
Gait kinematics at body weight support levels up to 30% most closely resemble gait 
kinematics at 0% body weight support. When utilizing a harness to provide body weight 
support greater than 30%, individuals are unable to generate the appropriate forces 
required for forward propulsion both for treadmill and overground walking. 13,17,21 
According to Threlkeld et al BWS levels of 50% and 70% produced a "decrease in 
cadence, an increase in step length, a reduction in stance phase, and a decrease in double 
limb support.,,10 (p 240) Due to this observation, utilizing high levels ofBWS would be 
detrimental to the concept ofPBWSTT. Ideally, one would decrease the amount ofBWS 
as the individual is able to distribute the weight appropriately throughout the entire gait 
cycle and perform the gait cycle without abnormaf postures. 12 
Treadmill speeds vary a great deal, but it is essential for the treadmill to increase 
speed by 0.1 miles per hour at a time.26 In the majority of studies, the initial speed 
chosen for individuals is dependent upon their self-selected over-ground walking speeds. 
If the individual was not able to ambulate over ground, a self-selected comfortable speed 
was chosen by the patient after the application of the harness and required BWS. The 
required BWS was determined by one of two ways: predetermined BWS amounts l7,21 or 
BWS amounts that were most comfortable for the subjects while allowing for appropriate 
gait kinematics such as lower extremity loading responses.8,1l,12 The speed of the 
treadmill was then adjusted to the comfort level of the patient, which was typically 
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slower than the demonstrated over ground speed. Therapists were able to perfonn 
manual gait corrections with the patient at the slower speed while also allowing for 
longer, uninterrupted therapy sessions.21 Hesse and company7 encourage BWS to 
decrease and treadmill speed to increase as soon as possible during rehabilitation to help 
engage the weight-bearing muscles and long-tenn cardiovascular benefits. Sullivan, 
Knowlton and Dobkin2 studied the effects of treadmill speed on locomotor recovery in 
patients who had sustained a CV A. This study had three treadmill training groups: 1) 
slow (0.5 mph), 2) fast (2.0 mph), and 3) variable (0.5, 1.0, 1.5, 2.0 mph). Comparing 
pre and post-training outcomes, the greatest improvement in self-selected over ground 
walking speed was found with the fast training group. The authors concluded that when 
individuals train at a speed comparable to an average adult's walking velocity (2.7mph), 
their self-selected overground walking velocity improved significantly.2 
In light of this infonnation, PBWSTT can be used as an effective tool for treating 
various impainnents and functional limitations. This enables the health professional to 
treat the patient at a functional level when compared to traditional physical therapy that 
has focused on one aspect of the gait cycle at a time. Using subjects without presence of 
an active pathology or a history of orthopedic pathology, this study will help in 
determining whether PBWSTT allows individuals to maintain proper gait kinematics and 
muscle activation during training sessions. 
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CHAPTER III 
METHODOLOGY 
Prior to the initiation ofthis study, the project was reviewed and approved by the 
University of North Dakota Institutional Review Board (see Appendix B). The methods 
used in this study are described below. 
Subjects 
Four subjects (three female, one male) were recruited at the School of Medicine and 
Health Sciences Physical Therapy Department. This was completed by placing a sign-up 
sheet on the physical therapy students' bulletin board. All subjects were required to be 
18 years of age or older and fulfill a two-hour commitment of time. Subjects had to be 
able to ambulate without the use of an assistive device and have prior treadmill 
experience. Participants were excluded from the study if they had a history of lower 
extremity orthopedic surgeries, injuries or use of orthotics. 
Prior to participation in the study, each subject was given a copy of an information 
and consent form (Appendix B). They were asked to read and sign the consent form 
indicating they understood the study and its objectives. Participants had to be able to 
read and understand the document and be competent and independent in their decision-
making. Participants were provided with a copy of the consent form to take with them in 
case they had further questions or concerns. They also were required to verbally answer 
the PAR-Q questionnaire to rule out any cardiovascular conditions (Appendix C). 
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Instrumentation 
Surface electrodes were utilized to record EMG activity. EMG activity was 
collected with a Noraxon Telemy08 telemetry unit (Noraxon USA, 13430 North 
Scottsdale Rd., Scottsdale, AZ 85254) and transmitted to a Noraxon Telemy08 receiver 
and then digitized by an analog digital interface board in Peak Analog Module. The Peak 
Motus5 system (Peak Performance, Englewood, CO) was used to store and analyze the 
EMG data. Final data are presented as percent of normalized EMG activity as an average 
of three gait cycles at each of the support trials. 
Motion analysis reflective markers were placed on each subject (see Procedure on 
page 18 for details). Four high-speed video cameras (Peak Performance High-Speed 
Video System, Englewood, CO, and Pulnix TM-640 Sequential Scanning Camera, 
Sunnyvale, CA) operating at 60 frames per second were set up to tape the activity. Four 
hi-fi videocassette recorders (NC BR-S3784 Hi-Fi VCR) recorded each trial onto super 
VHS tapes and encoded with a SMPTG time code generator. The Peak Calibration 
Frame (Peak Performance, Englewood, CO) was used to calibrate the cameras before the 
study began. A Lite-Gait body weight support system and a Gate Keeper Treadmill was 
used to apply the treadmill training. Following the recording of all trials, all subjects' 
movements were digitized using the Peak Motus software package. The tapes were 
played back on a Sanyo model GVR-S955 (Sanyo, 1200 W Artersia Blvd, Campton, CA 
90220) videocassette recorder for the purPose of digitization. Raw data coordinates were 
filtered using a Butterworth filter and conditioned at a cutoff frequency of six hertz. 
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Procedure 
Following reading and signing the consent form and passing of the Par-Q 
questionnaire, the electrode placement sites were determined and marked on the right 
side of body of each subject with a permanent marker according to EMG placement 
standards.29 After each area was marked, it was prepared by shaving the existing hair 
with an electric clipper and vigorously rubbing the skin with rubbing alcohol. Two 
electrodes were placed at seven locations while maintaining 1-2 millimeters distance 
between each electrode. The gluteus medius electrodes were located at the proximal 113 
distance between the iliac crest and greater trochanter. The erector spinae electrodes 
were horizontally aligned with the L3-4 interspace, four centimeters lateral to the mid-
line. The biceps femoris electrodes were placed at the midpoint between the ischial 
tuberosity and the lateral femoreal condyle. The electrodes for the gastrocnemius were 
placed over the muscle belly 114 the distance between the fibular head and calcaneous. 
The vastis lateralis electrodes were placed along a line.1/4 the distance from the lateral 
knee joint line to the anterior superior iliac spine CASIS). The rectus femoris electrodes 
were placed at the midpoint between the ASIS and superior pole of the patella. The 
anterior tibialis electrodes were placed over the muscle belly 113 of the distance from the 
inferior patellar pole to the lateral malleolus. A ground electrode was placed on the 
fibular head. 
Next, the harness was put on the subject using the greater trochanters as a reference 
to where the bottom of the harness should be located. After doing so, the motion analysis 
reflective markers were placed bilaterally on the following bony landmarks using double 
stick tape and rubber bands: greater trochanters, lateral femoral condyles, lateral malleoli, 
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ASIS, and the sacrum. Two small markers were also placed level with each other on the 
subject's shoes at the lateral calcaneous and head of the fifth metatarsal. A foot switch 
was taped under the plantar surface of the right heel of all sUbjects. All wires were 
connected to the electrodes and footswitch, and the subject's weight was taken (with 
harness donned) using a standard medical scale. After the weight was determined, 15% 
and 30% BWS levels were calculated and recorded. Each subject was randomly assigned 
the order ofBWS during testing before the study began. This was done by pulling the 
order out of a hat, and the ranpom assigrunents were for slack removed, 15% BWS and 
30% BWS. All subjects walked with 0% BWS to begin their testing. See Appendix D 
for picture of the set-up. 
Maximal voluntary contractions (MVC) for each muscle were recorded while 
performing manual muscle testing of the aforementioned muscles.3o The harness was 
attached to the support system, and each subject was instructed to stand with his/her feet 
shoulder-width apart. Each subject was also told to keep their hands off the treadmill 
hand-rails and to look away from the scale when BWS was increased. 
During each phase of the study, the subjects walked for three minutes. The first 
minute was to allow the subjects to adjust to the BWS amount. The data was then 
randomly collected for 8-second intervals - once during the second minute of walking 
and once during the third minute. After each phase, the subj ects were allowed to rest for 
1-2 minutes while the BWS amounts were adjusted according to the predetermined, 
randomized order. Throughout the study, subject's exertion levels were inquired about. 
As previously mentioned, the EMG activity was collected using the TeleMyo 900 
telemetry unit. It was transmitted from the telemetry transmitter to the TeleMyo 900 
19 
receiver which was interfaced with an analog to digital interface unit (Peak Performance 
Inc., Englewood, CO) utilizing a NorBNC board (Noraxon USA). The EMG files were 
then imported from the Peak Performance system into the Myoresearch EX software 
program (Noraxon USA) using a laptop computer. Using the Myoresearch XP (Noraxon, 
USA) software program, the EMG data was integrated and smoothed. EMG date was 
filtered, rectified, and normalized to the unweighted walking trial for each subject. Final 
data are presented as percent of normalized EMG activity as an average of three gait 
cycles at each ofthe support trials. The EMG data was analyzed using MyoResearch 
software package to make comparisons between muscle activity and weight bearing 
support levels. 
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CHAPTER IV 
RESULTS 
The purpose of this study was to evaluate muscle activation and gait kinematics 
during PBWSTT of individuals without pathological impairments. VMA and EMG were 
utilized in order to determine ifthere was a significant change in these variables between 
full weight bearing and mUltiple levels of body weight support. Our research questions 
were as follows: 1) Is there a difference in muscle activation between full weight-bearing 
ambulation and body-weight supported ambulation? and 2) Is there a difference in gait 
kinematics between full weight-bearing ambulation and body-weight supported 
ambulation? 
Data from subjects 1-4 was analyzed. The small sample size (n = 4) resulted in 
the need to run both parametric and non-parametric statistical measure. It was found that 
the non-parametric measures supported the parametric results; therefore, parametric 
results are reported in this study. 
Muscle Activation 
In order to answer research question number one, the researchers looked at the 
EMG of seven muscles. The muscles included were the gluteus medius, erector spinae, 
biceps femoris, gastrocnemius, vastus lateralis, rectus femoris, and anterior tibialis. The 
data from each muscle group was compared between all four subjects at all four levels of 
body-weight support (0%,3-6%, 15%, and 30%). This was computed using a repeated 
21 
measure, single-factor analysis of variance (ANOVA) in SPSS (Chicago, IL 60606). The 
required level of significance was set at p = 0.05. Table 1 illustrates the EMG means and 
standard deviations found for each of the seven muscle groups. 
Table 1: EMG Means and Standard Deviations for Tested Muscles (numbers are 
compare d b r (lOOo/c)) to ase me 0 
Gluteus Erector Biceps Gastroc- Vastus Rectus Anterior 
Medius Spinae Femoris nemius Lateralis Femoris Tibialis 
mean % mean % mean % mean % mean % mean % mean % 
Percentage Weight (std dey) (std dey) (std dey) (std dey) (std dey) (std dey) _(std dey) 
Bearing Removed 
0% 100 (0) 100 (0) .100 (0) 100 (0) 100 (0) 100 (0) 100 (0) 
129.65 109.58 111 .73 117.15 109.25 89.05 109.25 
3-6% (18.84) (37.63) (57.48) (23.93) (6.32) (7.87) (24.94) 
132.20 131.90 126.23 132.20 107.13 85.48 111.83 
15% (17.49) (18.04) (61 .18) (33.29) (20.42) (7.45) (26.61] 
99.35 125.28 113.68 110.90 119.95 88.85 118.48 
30% (14.77) (12.22) (55.83) (14.50) (19.74) (24.86) (10.52) 
The gluteus medius muscle activation was found to be significantly different 
between subjects (F(3,8) = 11.446; P = 0.003). The power for this test was 0.977 and 
partial eta squared was 0.811. A post-hoc analysis was then performed, and Scheffe 
results were found to show significant differences in gluteus medius activation between 
0% vs 3-6% (p = 0.017),0% vs 15% (p = 0.016),3-6% vs 30% (p = 0.015), 15% vs 30% 
(p = 0.015). 
The remaining six muscles did not show significant difference between muscle 
activation and weight-bearing percentages (see Table 2). It is also noted that the power 
for these six muscles was quite low. 
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Table 2: ANOY A Results for Muscle Activation 
Degrees of 
Freedom F Significance (p) Power 
Erector Spinae 3,8 1.585 0.267 0.275 
Biceps Femoris 3,8 0.375 0.773 0.096 
Gastrocnem ius 3,8 1.849 0.217 0.316 
Vastus Lateralis 3,8 0.525 0.677 0.116 
Rectus Femoris 3,8 0.555 0.659 0.121 
Anterior Tibialis 3,8 1.022 0.433 0.188 
Motion Analysis 
To answer research question number two, the researchers looked at both step 
length and ankle dorsiflexion. The data was compared between all four subjects at all 
four levels of body-weight support (0%,3-6%, 15%, and 30%). This was computed 
using a repeated measure, single-factor analysis of variance (ANOYA) in SPSS 
(Chicago, IL 60606). The required level of significance was set at p = 0.05. Step length 
was found to be significantly different between weight bearing conditions (F(3,9) = 
8.923; P = 0.005; partial eta squared = 0.748; power = 0.948). Post Hoc analysis was 
performed, and Scheffe results showed significant differences in step length between 0% 
vs 3-6% (p = 0.016) and 0% vs 30% (p = 0.009) (see Table 3). 
Table 3: Average Step Length (meters) for Each Subject at Each Level of Weight Bearing 
Removed 
Percentage 
Weight 
Bearing 
Subject 4 Removed Subject 1 Subject 2 Subject 3 
0% 0.50 0.52 0.50 0.49 
3-6% 0.47 0.49 0.48 0.47 
15% 0.49 0.49 0.48 0.48 
30% 0.47 0.47 0.48 0.48 
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Ankle dorsiflexion between subjects was not found to be significant (F(3,9) = 
2.176; P = 0.161; partial eta squared = 0.420; power = 0.383) (see Table 4). 
Table 4: Amount of Ankle Dorsiflexion (900 = neutral) for Each Subject at Each Level of 
Weight Bearing Removed 
Percentage 
Weight 
Bearing 
Removed Subject 1 Subject 2 Subject 3 Subject 4 
0% 95.40 97.10 95.70 94.60 
3-6% 94.70 94.80 98.10 91 .30 
15% 94.50 95.40 96.90 91 .00 
30% 93.90 94.40 96.30 90.00 
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CHAPTER V 
DISCUSSION 
Previous literature has shown the effectiveness of partial body weight support 
treadmill training (PBWSTT) for individuals after cerebrovascular accidents (CV A), 
traumatic brain injuries (TBI), spinal cord injuries (SCI), and other neurological and 
musculoskeletal pathologies. Positive benefits include improved cadence and stride 
length for individuals after CVA21 , improved gait kinematics at increased speeds13 and 
improved joint motion and EMG activit/O for individuals after a SCI. Visintin and 
Barbeau24 have shown PBWSTT facilitates a more normal gait pattern both in EMG 
activity and joint motion. 
As discussed in Chapter II, Field-Fote13 has stated the maximum body weight 
support to use for gait training is 30%. This allows for ambulation that most closely 
resembles gait kinematics at 0% BWS. Hesse, Konrad, and Uhlenbrock17 also supported 
the use of 30% BWS because their research had shown that BWS over this amount 
significantly reduced the muscle activation of the essential lower extremity weight-
bearing muscles. According to the results from our study, there was a significant 
difference between the electromyography (EMG) results ofthe gluteus medius when 0% 
weight support was compared to both 3-6% BWS and 15% BWS. We found no 
significant difference between 0% and 30% BWS, thus supporting the aforementioned 
researchers. 
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We believe that the increases in EMG activity during both 3-6% and 15% may be 
the result of the ability of individuals without impairments to adjust to the varying BWS 
levels. At 3-6% and 15% BWS, the subjects may have altered their muscle activity to 
compensate for the increase in support. At 30% BWS, the harness provided the most 
stabilizing support for the pelvis; therefore, the gluteus medius was not required to 
stabilize the pelvis as much. As discussed earlier, one of the determinants of gait is 
pelvic tilt. The pelvis tilts downward on the stance leg in order to lower the center of 
mass during ambulation. PBWSTT at 30% BWS does not allow the center of mass to 
lower; therefore, the gluteus medius does not be to be engaged to the same degree to 
maintain the pelvic tilt. 
There was no significant difference found between the firing of the erector spinae, 
biceps femoris, gastrocnemius, rectus femoris, and anterior tibialis at all levels of body 
weight support (Appendix E). Hesse, Konrad, and Uhlenbrock17 conducted a study using 
PBWSTT, and they also found EMG activity between 0%, 15%, and 30% BWS at the 
anterior tibialis, vastus lateralis, biceps femoris, and erector spinae was not significantly 
different. Trends showed decreases in the EMG activity of the vastus lateralis and 
anterior tibialis. Our current study does not support that trend. At 30% BWS, vastus 
lateralis and tibialis anterior showed the greatest amount ofEMG activity. 
In addition to EMG data, video motion analysis (VMA) was used to analyze both 
step length and ankle dorsiflexion between subjects at the various body weight support 
levels. The results of our study showed a significant difference in step length between 
amounts of body weight support of all four subjects. The greatest significance was found 
between 0% (0.5025 +/- 0.01 meters) and 30% (0.48 +/- O.Olmeters) BWS. Data gathered 
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to determine step length (in meters) was measured from the moment of initial contact to 
the moment ofterminal stance. This time frame was determined by the stepping on and 
off of the heel switch that was placed in the subject's right shoe. Individuals without 
impairments have a longer stride length compared to those with impairments. When our 
subjects were lifted by the increasing body weight support, they took shorter steps 
because the heel lifted earlier. Previous studies that have looked at people with 
impairments showed step length increases with increased body weight support. This is a 
result of the person's ability to take larger, more normal steps due to the fact that they can 
support themselves on hislher involved extremity/extremities. For example, Hesse and 
companyl studied seven subjects with hemiparesis using PBWSTT. These subjects had 
a 42% increase in stride length after PBWSTT therapy. 
Ankle dorsiflexion was not found to be significantly different between subjects at 
the various body weight support levels which is in contrast with the study done by 
Threlkeld et al lo who found that with increasing body weight support, ankle dorsiflexion 
increased at initial contact. Our study's results showed an overall decrease in average 
ankle dorsiflexion as body weight support increased; however, our average ankle 
dorsiflexion was based on the entire stance phase, not just initial contact. With increased 
body weight support, the tibia does not advance as far over the ankle at terminal stance. 
At terminal stance, you would expect the average person to have 10° of dorsiflexion. We 
hypothesize our subjects were not able to reach this point because oftheir shortened 
terminal stance which was shown in the area of step length. 
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Limitations 
We feel there are a number oflimitations that played into the final results of this 
study. First of all, due to the limited number of studies using PBWSTT on subjects 
without impairments, it is difficult to compare the results from this study to other studies 
previously performed. With only four subjects, our statistical power was extremely low 
(less than or equal to 0.316). Second of all, during data collection the foot switch did not 
function appropriately and had to be replaced twice. This may have affected step length 
measurements which were based on the proper workings of the foot switch. Thirdly, 
while digitizing, the computer program was unable to recognize data point consistently. 
This required a great deal of manual data point placement by the researchers. Human 
error could playa factor in the placement of these data points; however, the Butterworth 
filter was used to smooth out the data points. The fourth limitation noted was seen when 
subject number four appeared to be uncomfortable in the harness during greater body 
weight support levels (15% and 30%). Subject four was unable to ambulate in a 
"normal" manner, which may have altered his EMG and VMA results. The fifth 
limitation found is the matter of within subject variability. All people walk differently; 
therefore, you would not expect their EMG and VMA results to be identical. 
Recommendations 
We would recommend that future studies perform this same study again but with 
a larger sample size. This would allow for increased power, reliability, and validity of the 
results. In addition, using larger motion analysis reflectors would enable the researchers 
to have more accurate VMA results. We also recommend performing this study on 
patients with neurological or musculoskeletal insults to compare muscle activation and 
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gait kinematics between normal and impaired individuals (motor planning vs. motor 
learning). 
In conclusion, we found that PBWSTT did not significantly alter the gait pattern 
of normal individuals. This in turn will allow future studies to be performed on 
individuals who have impairments and limitations knowing that further compensation 
patterns will not be elicited from the use ofPBWSTT. 
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Appendix A 
The ASIA Impairment Scale 
A: Complete: No sensory or motor function is preserved in S4-S5. 
B: Incomplete: Sensory function is preserved below the neurological level and includes 
S4-S5 
C: Incomplete: Motor function is preserved below the neurological level. More than 
half ofthe key muscles below the neurological level. More than half of the key 
muscles below the neurological level are <3/5 strength. 
D: Incomplete: Motor function is preserved below the neurological level. At least half 
of the key muscles below the neurological level are ?:.3/5 strength. 
E: Normal. Sensory and motor function is normal. 
Figure 2: ASIA Impairment Scale (Adapted from Goodman and Boissonnaule j ) 
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Appendix B 
REPORT OF ACTION: EXEMPT/EXPEDITED REVIEW 
University of North Dakota Institutional Review Board 
Date: 4/8/2004 Project Number: I RB- 200404-323 
Principal Investigator: Flom-Meland, Cindy; Silbernagel, Jenny; Klempel, Amanda; Hanson, Melanie; Kingzett, 
Cherron 
Department: Physical Therapy 
Project Title: The Effects of Partial Body Weight Support Treadmill Training on Muscle Activation and Gait Kinematics 
with Normal Subjects 
The above referenced project was reviewed by a designated member for the University's Institutional Review Board 
on Apr;' 22. 2004 and the following action was taken: 
i1. Project approved. Expedited Review Category No. --11;';-1-1-"=---------------------
Next scheduled review must be before: ---.:A..:.<p:..:.r.....:;-,'--=2=.2L.' .....:2::...:0:....:0:....::5'---_________________ _ 
~Copies of the attached consent form with the IRB approval stamp dated Apr; 1 22, 2004 
must be used in obtaining consent for this study. 
Project approved. Exempt Review Category No. ______________________ _ 
o This approval is valid until as long as approved procedures are followed. No 
periodic review scheduled unless so stated in the Remarks Section. 
o Copies of the attached consent form with the IRB approval stamp dated 
must be used in obtaining consent for this study . 
, 
• Minor modifications required. The required corrections/additions must be submitted to ORPD for review and 
approval. This study may NOT be started UNTIL finallRB approval has been received. 
(See Remarks Section for further information.) 
o Project approval deferred. This study may not be started until finallRB approval has been received. 
(See Remarks Section for further information.) 
REMARKS: Any adverse occurrences in the course of the research project must be reported immediately to 
the IRS Chairperson or ORPD. 
Any changes in protocol or Consent Forms must receive IRB approval prior to being 
implemented. You must submit a memo with a copy of the Consent Form and a revised Human 
Subjects Review Form, with the appropriate signatures, to the Office of Research and Program 
Development for review and approval. 
PLEASE NOTE: Requested revisions for student proposals MUST include adviser's signature. All revisions 
MUST be highlighted. 
~ducation Requirements Completed. (Project cannot be started untillRB education requirements are met.) 
./ t 
cc: Chair, Physical Therapy; Dean, School of _ 
Medicine 
. the proposed project (clinical medical) is to be part of a research activity funded by a Federal Agency, a special assurance 
tatement or a completed 310 Form may be required. Contact ORPD to obtain the required documents. 
(Revised 10/2002) 
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University of North Dakota Human Subjects Review Form 
All research with human participants conducted by faculty, staff, and students associated with the University of North Dakota, 
must be reviewed and approved as prescribed by the University's policies and procedures goveming the use of human subjects. 
It is the intent of the University of North Dakota (UND), tlrrough the Institutional Review Board (IRB) and the Office of 
Research and Program Development (ORPD), to assist investigators engaged in human subject research to conduct their 
research along ethical guidelines reflecting professional as well as community standards. The University has an obligation to 
ensure that all research involving human subjects meets regulations established by the United States Code of Federal 
Regulations (CFR). When completing the Human Subjects Review Form, use the "IRB Checklist" for additional guidance. 
Please provide the information requested below: 
Principal Investigator: Cindy Flom-Meland, Jenny Silbemagel, Amanda Klempel, Melanie Hanson, Cherron Kingzett 
Telephone: 777-4130 E-mail Address: cfmeland@medicine.nodak.edu 
-----------------------------
Complete Mailing Address: PO Box 9037 PT 
--------------------------------------------------------------------
SchooVCollege: School of Medicine and Health Sciences Department: Physical Therapy 
Student Adviser (if applicable): Cindy Flom-Meland 
--~------------------------------------------------------------
Telephone: 777-4130 E-mail Address: cfmeland(a),medicine.nodak.edu 
Address or Box #: PO Box 9037 PT 
SchooVCollege: School of Medicine and Health Sciences Department: Physical Therapy 
Project Title: The effects of partial body weight support treadmill training on muscle activation and gait kinematics with 
normal subjects 
Proposed Project Dates: Beginning Date: 05/01/04 Completion Date: 05/01105 
----------------------
--~~~~~--~~~--(Including data analysis) 
Funding agencies supporting this research: NA 
(A copy ofthefillldiltg proposal/or each ageltcy idelltified above MUST be attached to this proposalwitelt submitted.) 
Does the Principal Investigator or any researcher associated with this project have a financial interest 
in the results of this project? If yes, please submit, on a separate piece of paper, an additional 
YES or X NO explanation of the financial interest (other than receipt of a grant) 
If your project has been or will be submitted to other IRB's, list those Boards below, along with the status of each proposal. 
Date submitted: 
-------------------------------------
Status: 
---------
Approved __ Pending 
Date submitted: 
--------------------------------------
Status: 
---------
Approved Pending 
Type of Project: Check "Yes" or "No" for each of the following. 
X YES or NO New Project YES or X NO Dissertation/Thesis 
YES or X NO ContinuationlRenewal X YES or NO Student Research Project 
Is this a Protocol Change for previously approved project? If yes, submit a signed copy of this form 
YES or X NO with the changes bolded or highlighted. 
Does your project involve medical record information? If yes, complete the HIPAA Compliance 
YES or X NO Application and submit it with this form. 
Does your project include Genetic Research? If yes, refer to Chapter 3 of the Researcher Handbook 
YES or X NO for additional guidelines regarding your topic. 
Does your project include Intemet Research? If yes, refer to Chapter 3 of the Researcher Handbook 
YES or X NO for additional guidelines regarding your topic . 
Will subjects or data be provided by Altru Health Systems? If yes, submit two copies of the 
YES or X NO proposal. A copy of the proposal will be provided to Altru. 
Will research subjects be recruited at another organization (e .g., hospitals, schools, YMCA) or will 
YES or X NO assistance with the data collection be obtained from another organization? 
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Ifyes,li~allinstirutions : ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~_ 
Letters from each organization must accompany this proposal. Each letter must illustrate that the organization understands 
their involvement in that study, and agrees to participate in the study. Letters must include the name and title of the 
individual signing the letter and, if possible, should be printed on letterhead. 
Subject Classification: This study will involve subjects who are in the following special populations: Check all that apply. 
___ Minors « 18 years) X UND Students 
Prisoners 
~~-
Pregnant WomenlFetuses 
Persons with impaired ability to understand their involvement and/or consequences of participation in this research 
Other 
~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-
For information about protections for each of the special populations, refer to Chapter 5 of the Researcher Handbook. 
This study will involve: Check all that apply. 
___ Deception Stem Cells 
---
Radiation Discarded Tissue 
---
Fetal Tissue 
~~-
___ New Dmgs (JND) 
Human Blood or Fluids 
---
___ Non-approved Use ofDrug(s) 
Recombinant DNA Other 
X None of the above will be involved in this study 
I. Project Overview 
Please provide a brief explanation (limit to 200 words or less) of the rationale and purpose of the study, introduction of any 
sponsor(s) of the srudy, and justification for use of human subjects and/or special populations (e .g., vulnerable populations such 
as minors, prisoners, pregnant women/fetuses) . 
Gait dysfunction is a common result of stroke, traumatic brain injury, spinal cord injury and other neurological insults. Many 
individuals who suffer from these insults are non-ambulatory for some length of time. Therefore, gait training is key to the 
rehabilitation process. Traditionally, physical therapists focus on approaches of strengthening and single-movement practices. 
These approaches include NDT techniques. Current approaches in the rehabilitation process concentrate on task-specific gait 
training, which includes partial body weight support treadmill training (PBWSTT). 
PBWSTT allows a patient to perform multiple, complex ambulatory movements through the use of a supportive harness. This is 
done by decreasing the patient's body weight by a given percentage while providing trunk and equilibrium stabilization. Current 
literature states the use of 40% or less body weight support for rehabilitation provides appropriate support without alteration of 
normal gait kinematics. Through the use ofEMG and motion analysis, we will analyze normal individuals ' gait patterns and 
muscle activity at a constant speed and varying body weight support. We believe that there will not be a significant deviation in 
EMG measurements or gait kinematics as compared to normal, full weight-bearing ambulation. 
II. Protocol Description 
Please provide a succinct description of the procedures to be used by addressing the instructions under each of the following 
categories. Individuals conducting clinical research please refer to the "Guidelines for Clinical-Research Protocols" on the Office 
of Research and Program Development website. 
1. Subject Selection. 
a) Describe recmitment procedures (i.e., how subjects will be recruited, who will recruit them, where and when they will 
be recmited and for how long) and include copies of any advertisements, fliers, etc., that will be used to recruit subjects. 
Subjects will be recruited from the School of Medicine and Health Sciences Physical Therapy Department by the 
researchers. This will be done by placing a sign-up sheet on the physical therapy students' bulletin board. Each subject 
will be recmited for a one-time, 2-hour commitment. A total of20 subjects will be recruited. 
b) Describe your subject selection procedures and criteria, paying special attention to the rationale for including subjects from 
any of the categories listed in the "Subject Classification" section above. 
All subjects must be 18 years of age or older and will be asked to fulfill a 2-hour commitment of time. Subjects 
must be able to ambulate without the use of an assistive device and have prior treadmill experience of greater than a one-
time use for 5 minutes. 
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c} Describe your exclusionary criteria and provide a rationale for excluding subject categories. 
Participants will be excluded from the study if they have a history ofIower extremity orthopedic surgeries, injuries, or use 
of orthotics. They will also be excluded if they have a prior or present history of cardiovascular conditions. Subjects will 
be asked the Par-Q questionnaire to IUle out existing cardiovascular conditions (see attached form) . No written 
documentation will be kept regarding this form for each individual subject. 
d) Describe the estimated number of subjects that will participate and the rationale for using that number of subjects. 
This study will include 20 subjects due to the fact this is a pilot study. 
e) Specify the potential for valid results. If you have used a power analysis to determine the number of subjects, describe 
your method. 
Research has shown that EMG and motion analysis are valid, objective tools. A power analysis was not performed. Due to 
the fact that this is a pilot study to standardize the treatment protocol for future studies. 
2. Description of Methodology. 
a) Describe the procedures used to obtain informed consent. 
Prior to participation in the study, each subject will be given a copy of an information and consent form. They will be 
asked to read and sign the consent form indicating they understand the study and its objectives. They will be provided with 
the consent form to take with them in case further questions/concems arise. The researcher or subject has the right to 
terminate participation at any time during the study with out penalty. 
b) Describe where the research will be conducted. 
Research will be conducted in the Physical Therapy Department at the University of North Dakota. 
c) Indicate who will carry out the research procedures. 
The four student researchers, along with the student advisor and 2 faculty members from the Department of Physical 
Therapy at UND will conduct the research procedures. 
d) Briefly describe the procedures and techniques to be used and the amount oftime that is required by the subjects to 
complete them. 
After obtaining informed consent, each participant will be prepared for both EMG and motion analysis . In order to perform 
EMG, self-adhesive electrodes will be placed on the subject's skin after the area has been shaved using clippers and cleaned 
with IUbbing alcohol. The electrodes will be placed on the following muscles according to EMG standards: right anterior 
tibialis, gastrocnemius, rectus femoris, vastus lateralis, biceps femoris, gluteus medius and erector spinae. Each electrode 
will be placed over motor points of the above muscles. Pressure switches will be located on the plantar surface of the right 
calcaneous to detemline when initial contact occurs and on the planter surface of the first metatarsal head to detelmine toe 
off phase of the gait cycle. A ground electrode will be placed on the subject's right fibular head. The EMG signals will be 
transmitted to the Noracon Telemy08 Receiver and then fed into a computer for display and recording of data. Maximum 
voluntary contractions of the previously mentioned muscles will be measured during manual muscle testing techniques 
administered by the testers to determine baseline. This muscle activity will be recorded and considered to be the 100% 
activity level. This is used to normalize the EMG data for analysis . 
Video analysis will be used to measure lower extremity range of motion during the activity . Motion analysis reflective 
markers wiII be placed on the following bony landmarks: right greater trochanter, lateral femoral condyle, lateral malleolus, 
saClUm, AS IS, and two small markers will be placed on the subjects' shoes at the lateral calcaneous and head of the fifth 
metatarsal (these two markers will be level with each other). The reflective markers will be attached to the individual using 
double-stick tape. Four video cameras will be placed around the subject and will film lower extremity movements. This 
will be recorded on videotapes and be transferred to a computer for analysis . Before performing the activity, alI subjects 
will be weighed on a standard scale in order to determine the appropriate level of body weight support used during the 
activity. 
Once the subject has been prepared, he/she wilI begin to walk on a treadmill at 3 miles per hour (1 .34 meters per second). 
EMG and motion analysis measurements will be taken at this time to determine the subject's baseline numbers . After the 
subject has walked 3 minutes, the hamess will then be donned. After the harness is donned, the subject will randomly select 
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the order of treatments received: slack in the support straps removed (3-6% body weight support), 15% or 30% of body 
weight support. With each treatment, the subjects will ambulate 3 minutes, rest for 1 minute, and then ambulate for another 
3 minutes. Data collection will be performed during the 1-2 minute span and 2-3 minute span of this final ambulatory 
session. The randomization will be determined by drawing the percentages out of a hat. After all subjects complete the 
study, the EMG and motion analysis recordings will be analyzed. 
e) Describe audio/visual procedures and proper disposal of tapes. 
Motion analysis will be performed using four video cameras and will be recorded on video tape. These tapes 
will be secured in a locked cabinet in the Physical Therapy Department at the University ofNOlth Dakota. Participant 
consent forms will also be kept in a locked cabinet separate from the videos. Records will be destroyed using a paper 
shredder three years after conclusion of the study. The four student researchers, student advisor, and two faculty 
members will be the only individuals who have access to this information. 
f) Describe the qualifications of the individuals conducting all procedures used in the study. 
The four student researchers are students in the UND physical therapy program and have experience with all tools utilized 
in the study. The student advisor and faculty members that are assisting with this project are trained in the use of Lite-Gait, 
EMG, and motion analysis. All researchers are certified in CPR. 
g) Describe compensation procedures (payment or class credit, etc.) . 
N/A 
Attachments Necessary: Copies of all instruments (such as surveylinterview questions, data collection forms completed by 
subjects, etc.) must be attached to this proposal. 
See attached: Subject information and consent form. 
3. Risk Identification. 
a} Clearly describe the anticipated risks to the subject/others including any physical, emotional, and financial risks that might 
result from this study. 
When using any type of exercise equipment, there is always a slight risk for minor injury (i .e. muscle strain, fatigue , falls , 
etc.). This study consists of low-level exercise. The level of exertion from participating in this study is comparable to the 
subjects ' daily routines (walking to a car, walking to class, etc.). The subjects may have mild skin ilTitation from 
application of the EMG electrodes due to the adhesive. 
c} Indicate whether there will be a way to link subject responses and/or data sheets to consent forms , and ifso, what the 
justification is for having that link. 
Subject and re~ult information will not be linked to the consent form in order to protect the confidentiality of participants. 
4. Subject Protection. 
a} Describe precautions you will take to minimize potential risks to the subjects (e.g., sterile conditions, informing subjects 
that some individuals may have strong emotional reactions to the procedures, debriefing, etc.). 
Participants will be informed of possible skin ilTitation from the self-adhesive electrodes, rubbing alcohol, and/or double-
stick tape. They will also be educated on the use of treadmills and the safety features of the treadmill. 
b) Describe procedures you will implement to protect confidentiality (such as coding subject data, removing identifying 
information, reporting data in aggregate form, etc.). 
Subject and result information will not be linked to the consent form in order to protect the confidentiality of participants. 
Names will not be included on subject research data forms . Rather, Subject numbers 1-20 will be used to identify the 
palticipants. 
c) Indicate that the subject will be provided with a copy of the consent form and how this will be done. 
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Prior to participation in the study, subjects will be given a copy of an information and consent form (see attached) to 
read and sign. Participants will be able to read and understand the document and will be competent and independent in 
their decision-making. Participants will be provided with a copy of the consent form for their records. 
d) Describe the protocol regarding record retention. Please indicate that research data from this study and consent forms 
will both be retained in separate locked locations for a minimum of three years following the completion of the study. 
Describe: 1) the storage location of the research data (separate from consent forms and subj ect personal data) 
2) who will have access to the data 
3) how the data will be destroyed 
4) the storage location of consent forms and personal data (separate from research data) 
5) how the consent forms will be destroyed 
Results from the study will be secured in a locked cabinet in the Physical Therapy Department at the University of 
North Dakota. Participant consent forms will be kept separate from the research data forms . Records will be destroyed 
using a paper shredder three years after conclusion of the study. The four student researchers, student advisor, and two 
faculty members will be the only individuals who have access to this information. 
e) Describe procedures to deal with adverse reactions (refenals to helping agencies, procedures for dealing with trauma, etc .). 
If injury occurs during the study, medical treatment will be available as it would be to any individual in the community. 
The participant and his/her third party payer will be responsible for paying for such treatment. 
f) Include an explanation of medical treatment available if injury or adverse reaction occurs and responsibility for costs 
involved. 
If injury occurs during the study, medical treatment will be available as it would be to any individual in the community. 
The participant and his/her third party payer will be responsible for paying for such treatment. 
III. Benefits of the Study 
Clearly describe the benefits to the subject and to society resulting from this study (such as learning experiences, services 
received, etc.). Please note: payment is not a benefit and should be listed in the Protocol Description section under 
Methodology. 
The purpose of this study is to evaluate gait kinematics ofPBWSTT with normal individuals to detern1ine if there are any gait 
deviations as a result. According to our hypothesis, we hope to find no significant gait deviations (kinematics and muscle 
activation) with the use ofPBWSTT. With these results, future studies can be conducted to apply the findings to populations 
who will benefit from such task-specific gait training. In conclusion, the positive benefits from PBWSTT can canyover to 
functional over-ground gait activities. 
IV. Consent Form 
A copy of the consent form must be attached to this proposal. If no consent form is to be used, document the procedures to be 
used to protect human subjects. Refer to the ORPD website for further information regarding consent form regulations. 
Please note: Regulations require that all consent forms, and all pages of the consent forms, be kept for a minimum of 3 years 
after the completion of the study, even if subject does not continue participation. The consent form must be written in 
language that can easily be read by the subject population and any use of jargon or technical language should be avoided. It is 
recommended that the consent form be written in the third person (please see the examples on the ORPD website). A two inch 
by two inch blank space must be left on the bottom of each page of the consent form for the IRB approval stamp. The consent 
form must include the following elements: 
a) An introduction of the principal investigator 
b) An explanation of the purposes of the research 
c) The expected duration of subject participation 
d) A brief summary of the project procedures 
e) A description of the benefits to the subject/others anticipated from this study 
f) A paragraph describing any reasonably foreseeable risks or discomforts to the subject 
g) Disclosure of any alternative procedures/treatments that are advantageous to the subject 
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h) An explanation of compensation/medical treatment available if injury occurs. 
i) A description of how confidentiality of subjects and data will be maintained. Indicate that the data and consent forms 
will be stored separately for at least three years following the completion of the study. Indicate where, in general, the 
data and consent documents will be stored and who will have access. The following statement must be included in all 
consent forms and informational letters: "Only the researcher, the adviser, [if applicable] and people who audit IRB 
procedures will have access to the data." Please make appropriate additions to the persons that may have access to 
your research data. Indicate how the data will be disposed of. Be sure to list any mandatory reporting requirements 
that may require breaking confidentiality. 
j) The names, telephone numbers and addresses of two individuals to contact for information (generally the student and 
student adviser) . This information should be included in the following statement: "If you have questions about the 
research, please call (insert Principal Investigator's name) at (insert phone number of Principal Investigator) or (insert 
Adviser ' s name) at (insert Adviser ' s phone number) . If you have any other questions or concerns, please call the 
Office of Research and Program Development at 777-4279." 
k) If applicable: an explanation of who to contact in the event of a research-related injury to the subject. 
I) If applicable: an explanation of financial interest must be included. 
m) Regarding participation in the study: 
1) An indication that participation is voluntary and that no penalties or loss of benefits will result from refusal to 
participate. 
2) An indication that the subject may discontinue participation at any time without penalty, with an explanation of how 
they can discontinue participation. 
3) An explanation of circumstances which may result in the termination of a subject's participation in the study. 
4) A description of any anticipated costs to the subj ect. 
5) A statement indicating whether the subject will be informed of the findings of the study. 
6) A statement indicating that the subject will receive a copy of the consent form. 
By signing below, you are verifying that the information provided in the Human Subjects Review Form and attached 
information is accurate and that the project will be completed as indicated. 
Signatures: 
(Principal Investigator) Date: 
(Student Adviser) Date: 
Requirements for submitting proposals: 
Additional information can be found at the ORPD website at www.und.nodak.edu/dept/orpd 
Original Proposals and all attachments should be submitted to the Office of Research and Program Development, P.O. Box 7134, 
Grand Forks, ND 58202-7134, or brought to Room 105, Twamley Hall. 
Prior to receiving IRB approval, researchers must complete the required IRE human subjects' education. Please go to 
http://www.und.nodak.eduJdept/orpd/regucomrnlirb/Default.htrn for more information. 
The criteria for determining what category your proposal will be reviewed under is listed on page 3 of the IRB Checklist. Your 
reviewer will assign a review category to your proposal. Should your protocol require full Board review, you will need to 
provide additional copies. Further information can be found on the ORPD website regarding required copies and IRB review 
categories, or you may call the ORPD office at 701 777-4279. 
In cases where the proposed work is part of a proposal to a potential funding source, one copy of the completed proposal to the 
funding agency (agreement/contract if there is no proposal) must be attached to the completed Human Subjects Review Form if 
the proposal is non-clinical ; 7 copies if the proposal is clinical-medical. If the proposed work is being conducted for a 
pharmaceutical company, 7 copies of the company's protocol must be provided. 
Please Note: Student Researchers must complete the "Student Consent to Release of Educational Record". 
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INFORMATION AND CONSENT FORM 
The Effect of Partial Body Weight Support Treadmill Training on Muscle Activation and 
Gait Kinematics within Normal Subjects 
You are invited to participate in a research study conducted by Cindy Flom-Meland, 
physical therapy professor at the University of North Dakota, and Jenny Silbernagel, 
Amanda Klempel, Melanie Hanson and Cherron Kingzett, students of physical therapy at 
the University of North Dakota. The purpose of our study is to analyze the effects of 
partial body weight support treadmill training (PBWSTT) on individuals without 
problems with walking. 
You will be excluded from this study if you are under the age of 18, have a history of 
serious injuries and/or surgeries involving the legs, have a history of cardiovascular 
conditions, use prescription orthotics in your shoes or need the use of a cane, walker, 
crutches, etc. to walk. 
In order to participate in this study, you will need to be able to commit to a one-time, 2-
hour time period. During this time, you will be expected to walk on a treadmill at 3 miles 
per hour for approximately 30 minutes. The rest of the time commitment will occur prior 
to the treadmill walking and includes having electrodes placed on various muscles of the 
right leg and reflector markers placed on various bony landmarks on both legs and shoes. 
Your participation in this study will allow us to determine if PBWSTT changes muscle 
and body movements when compared to walking without any support. Your results will 
benefit future researchers when they are applying the PBWSTT to patients with walking 
disabilities. 
This fonn of exercise is considered to be a low-risk activity; however, with any type of 
exercise, there is some risk for injury. These risks will be minimized with proper training 
on the treadmill as well as guidance by the researchers. The electrodes used in this study 
may possibly cause mild skin irritation. If injury occurs while this study is being 
conducted, medical treatment will be available as it is to a member of the general public 
in similar circumstances. Payment for any medical treatment will be covered by you and 
your third party payer. By signing this document, you are not giving up any legal rights 
you may have in the case of negligence or other legal fault of anyone that is involved in 
the study. 
The information obtained in this study will be kept confidential. Your name and 
identifying information linking you to this study will not be revealed at any time. The 
results from this study will be securely kept in the Physical Therapy Department at the 
University of North Dakota. The only individuals who will have access to these results 
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include the researchers named above and the individuals at the University of North 
Dakota who audit research projects on campus. They will be destroyed three years after 
the conclusion of the study. There will be no financial compensation awarded to either 
you or the researchers associated with involvement in this study. 
Participation in this study is entirely voluntary. Your decision whether or not to 
participate will not change your future relations with the University of North Dakota. If 
you decide to participate, you or the investigators can choose to discontinue pat1icipation 
at any time during this study without penalty. 
If you have any questions or concerns regarding this study at any time, please feel free to 
contact Cindy Flom-Meland at the University of North Dakota at 777-2831 or 775-2476. 
You can also reach any of the student researchers through the Department of Physical 
Therapy at the University of North Dakota between the office hours of 8:00AM-4:30PM 
at 777-2831. If you have any other questions or concerns, please call the Office of 
Research and Program Development at 777-4279. 
I HAVE READ AND UNDERSTAND THE ABOVE INFORMATION AND 
WILLINGLY AGREE TO P ARTICIP ATE IN THIS STUDY. ALL OF MY 
QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED TO ASK ANY 
QUESTIONS THAT I MAY HAVE CONCERNING THIS STUDY IN THE FUTURE. 
A COpy OF THIS CONSENT FORM HAS BEEN GIVEN TO ME. 
Participant's Signature Date 
Investigator's Signature Date 
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Appendix C 
Par-Q and You 
Y / N 1. Has your doctor ever said that you have a heart condition and that you should 
only do physical activity recommended by a doctor? 
Y / N 2. Do you feel pain in your chest when you do physical activity? 
Y / N 3. In the past month, have you had chest pain when you were not doing physical 
activity 
Y / N 4. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
Y / N 5. Do you have a bone or joint problem that could be made worse by a change in 
your physical activity? 
Y / N 6. Is your doctor currently prescribing drugs (for example, water pills) for your 
blood pressure or heart? 
Y / N 7. Do you know of any other reason why you should not do physical activity? 
Figure 3: Par-Q Questionnaire (Adapted from the Canadian Society for Exercise 
Physiology8) 
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Appendix D 
Figure 4: Set-up of Lite-Gait, treadmill, EMG, and VMA with subject. 
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Appendix E 
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